aTYR PHARMA INC Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- aTYR PHARMA INC stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $17.00K.
- aTYR PHARMA INC stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $2.00K.
- aTYR PHARMA INC stock issued during period, value, stock options exercised for the quarter ending 2022-03-31 was $1.00K.
- aTYR PHARMA INC stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $58.00K.
- aTYR PHARMA INC stock issued during period, value, stock options exercised for fiscal 2025 was $19.00K.
- aTYR PHARMA INC stock issued during period, value, stock options exercised for fiscal 2022 was $1.00K, a 98.39% decline from fiscal 2021.
- aTYR PHARMA INC stock issued during period, value, stock options exercised for fiscal 2021 was $62.00K.
- aTYR PHARMA INC stock issued during period, value, stock options exercised for fiscal 2016 was $20.00K, a 96.26% decline from fiscal 2015.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $19.00K 10-K · filed 2026-03-05 | |
| 2025-06-30 | $17.00K 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $2.00K 10-Q · filed 2026-08-07 | |
| 2022-12-31 | $1.00K 10-K · filed 2025-03-13 | |
| 2022-03-31 | $1.00K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $62.00K 10-K · filed 2024-03-14 | |
| 2021-09-30 | $58.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $1.00K 10-Q · filed 2022-11-14 | |
| 2016-12-31 | $20.00K 10-K · filed 2017-03-16 | |
| 2015-12-31 | $535.00K 10-K · filed 2018-03-20 | |
| 2014-12-31 | $72.00K 10-K · filed 2017-03-16 | |
| 2013-12-31 | $77.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |